Wei Bao

675 total citations
36 papers, 529 citations indexed

About

Wei Bao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wei Bao has authored 36 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Wei Bao's work include Cancer-related molecular mechanisms research (6 papers), Enzyme Production and Characterization (5 papers) and Ferroptosis and cancer prognosis (3 papers). Wei Bao is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Enzyme Production and Characterization (5 papers) and Ferroptosis and cancer prognosis (3 papers). Wei Bao collaborates with scholars based in China, Hong Kong and Macao. Wei Bao's co-authors include Guolin Zou, Zhongliang Zheng, Jiachuan Lei, Jianqing Yu, Hui Liu, Hongxia Cheng, Yan Jia, Chunya Li, Shengshui Hu and Yong Ma and has published in prestigious journals such as The Journal of Physical Chemistry B, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Wei Bao

31 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Bao China	14	308	114	102	81	65	36	529
David Vásquez Chile	15	275 0.9×	64 0.6×	169 1.7×	115 1.4×	17 0.3×	36	750
Shoujun Yuan China	17	466 1.5×	37 0.3×	132 1.3×	116 1.4×	49 0.8×	38	812
Yasuyo Suga Japan	17	391 1.3×	27 0.2×	175 1.7×	90 1.1×	70 1.1×	23	1.0k
Cynthia A. Mattingly United States	12	352 1.1×	41 0.4×	187 1.8×	61 0.8×	20 0.3×	17	698
İlhan Yaylım Türkiye	17	395 1.3×	24 0.2×	144 1.4×	160 2.0×	37 0.6×	76	798
Adrianna Gielecińska Poland	13	403 1.3×	23 0.2×	162 1.6×	124 1.5×	36 0.6×	21	846
Kuan‐Chun Huang United States	12	298 1.0×	35 0.3×	151 1.5×	41 0.5×	24 0.4×	20	558
Jiqing Jiang United States	18	1.1k 3.5×	170 1.5×	162 1.6×	50 0.6×	47 0.7×	24	1.6k
Abbas Pirpour Tazehkand Iran	11	307 1.0×	20 0.2×	92 0.9×	101 1.2×	34 0.5×	15	444

Countries citing papers authored by Wei Bao

Since Specialization

Citations

This map shows the geographic impact of Wei Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Bao more than expected).

Fields of papers citing papers by Wei Bao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Bao. The network helps show where Wei Bao may publish in the future.

Co-authorship network of co-authors of Wei Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Bao. A scholar is included among the top collaborators of Wei Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Bao. Wei Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xinxin, Guoxin Wang, Wei Bao, et al.. (2025). Pathologic complete response to pralsetinib in stage IV RET-positive non-small cell lung cancer: A case report. Respiratory Medicine Case Reports. 54. 102186–102186.

Ni, Bing, Wei Bao, Junqi Zhang, et al.. (2025). CAV1 promotes epithelial-to-mesenchymal transition (EMT) and chronic renal allograft interstitial fibrosis by activating the ferroptosis pathway. Frontiers in Immunology. 16. 1523855–1523855.

Xu, Minghui, et al.. (2024). Behavior-based pricing and wholesale contracting in competing supply chains with informative advertising. Journal of the Operational Research Society. 76(6). 1140–1155. 2 indexed citations

Xie, Binbin, Faquan Lin, Wei Bao, et al.. (2023). Long noncoding RNA00324 is involved in the inflammation of rheumatoid arthritis by targeting miR‐10a‐5p via the NF‐κB pathway. Immunity Inflammation and Disease. 11(6). e906–e906. 5 indexed citations

Bao, Wei, Hao Wan, Xiaoping Yu, et al.. (2023). Model for predicting prognosis and immunotherapy based on CD+8 T cells infiltration in neuroblastoma. Journal of Cancer Research and Clinical Oncology. 149(12). 9839–9855. 1 indexed citations

Wang, Wei, et al.. (2023). Construction of an m6A- and neutrophil extracellular traps-related lncRNA model to predict hepatocellular carcinoma prognosis and immune landscape. Frontiers in Immunology. 14. 1231543–1231543. 3 indexed citations

Sun, Xiaochen, et al.. (2021). TAGLN Is Downregulated by TRAF6-Mediated Proteasomal Degradation in Prostate Cancer Cells. Molecular Cancer Research. 19(7). 1113–1122. 10 indexed citations

Wang, Xinbo, et al.. (2021). Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients. Frontiers in Surgery. 8. 771587–771587. 6 indexed citations

Bao, Wei, et al.. (2020). Targeting BCL10 by small peptides for the treatment of B cell lymphoma. Theranostics. 10(25). 11622–11636. 8 indexed citations

10.

Xue, Mingshan, Hui‐Qi Qu, Teng Zhang, et al.. (2020). Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19. ERJ Open Research. 7(1). 741–2020. 15 indexed citations

11.

Li, Xi, Qi Wang, Guoying Deng, et al.. (2019). Porous Se@SiO2 nanospheres attenuate cisplatin-induced acute kidney injury via activation of Sirt1. Toxicology and Applied Pharmacology. 380. 114704–114704. 28 indexed citations

12.

Bao, Wei, et al.. (2017). MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL. Journal of Neuropathology & Experimental Neurology. 76(11). 942–948. 19 indexed citations

13.

Deng, Xiongwei, Wei Bao, Li Zhu, et al.. (2015). Improving the activity of the subtilisin nattokinase by site-directed mutagenesis and molecular dynamics simulation. Biochemical and Biophysical Research Communications. 465(3). 580–586. 32 indexed citations

14.

Jia, Yan, Xinhua Cao, Yu Deng, et al.. (2014). Four residues of propeptide are essential for precursor folding of nattokinase. Acta Biochimica et Biophysica Sinica. 46(11). 957–964. 9 indexed citations

15.

Cheng, Hongxia, et al.. (2011). Studies on the interaction between docetaxel and human hemoglobin by spectroscopic analysis and molecular docking. Journal of Photochemistry and Photobiology B Biology. 105(2). 126–132. 44 indexed citations

16.

Bao, Wei, et al.. (2011). Directed evolution improves the fibrinolytic activity of nattokinase from Bacillus natto. FEMS Microbiology Letters. 325(2). 155–161. 35 indexed citations

17.

Jia, Yan, Hui Liu, Wei Bao, et al.. (2010). Functional analysis of propeptide as an intramolecular chaperone for in vivo folding of subtilisin nattokinase. FEBS Letters. 584(23). 4789–4796. 14 indexed citations

18.

Bao, Wei. (2009). Treatment of polycystic ovary syndrome with nourishing kidney and resolving phlegm combined with blood-activating. Tianjin Journal of Traditional Chinese Medicine. 2 indexed citations

19.

Zheng, Zhongliang, et al.. (2009). Enhancement of oxidative stability of the subtilisin nattokinase by site-directed mutagenesis expressed in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1794(11). 1566–1572. 40 indexed citations

20.

Li, Chunya, Changfa Wang, Yong Ma, Wei Bao, & Shengshui Hu. (2005). A novel amperometric sensor and chromatographic detector for determination of parathion. Analytical and Bioanalytical Chemistry. 381(5). 1049–1055. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact